Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -6.60% | 123.47 | 0.0% | $1121.14m | |
| OCGN | Ocugen, Inc. | -1.26% | 8.63 | 0.0% | $797.67m | |
| AMGN | Amgen, Inc. | 0.04% | 227.81 | 1.3% | $546.41m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.35% | 463.19 | 2.7% | $534.62m | |
| NVAX | Novavax, Inc. | -9.71% | 157.87 | 92.9% | $533.68m | |
| GILD | Gilead Sciences, Inc. | 0.20% | 64.75 | 1.0% | $502.19m | |
| ILMN | Illumina, Inc. | -3.82% | 383.62 | 3.5% | $481.24m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.76% | 213.58 | 1.9% | $461.68m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.03% | 150.06 | 2.0% | $329.21m | |
| BNGO | BioNano Genomics, Inc. | 8.67% | 7.77 | 0.0% | $322.31m | |
| CRSP | CRISPR Therapeutics AG | -0.90% | 113.62 | 0.6% | $321.43m | |
| BIIB | Biogen, Inc. | -0.26% | 270.01 | 1.7% | $296.77m | |
| EXAS | EXACT Sciences Corp. | -4.17% | 116.57 | 18.4% | $244.18m | |
| SGEN | Seagen Inc. | -0.45% | 148.68 | 5.8% | $208.59m | |
| PACB | Pacific Biosciences of California, Inc. | -6.49% | 27.37 | 7.2% | $176.05m |
Company Profile
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.